23. Symposium of the AGNP

Abel, A.

FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain

Achenbach, U.

New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)

Ackenheil, M.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Ackl, N.

Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia

Adena, S. M.

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

The effects of RS-86 on sleep with respect to depression and HLA-type

Adler, L.

Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder

Adli, M.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Agelink, M.

Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?

Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

Aicher, S.

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Ajdacic, V.

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Akkan, R.

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Albrecht, N.

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

The significance of non-REM sleep for memory processes in elderly subjects

Albus, M.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Aldenhoff, J. B.

Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)

Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

Novel object presentation affects sleep-wake behavior in rats

Perinatal, subchronic NMDA receptor antagonism attenuates behavior from childhood to adulthood in rats

Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression

A new concept for crisis management in borderline patients

Alexander, G. E.

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

Alexson, S.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Alling, C.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Alt, A.

Leptin levels of alcohol abstainers and detoxification patients are not different

Altshuler, L.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Amann, B.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Amberg, R.

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Anghelescu, I.

Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder

From mouse models to human behavior: Testing candidate genes for alcoholism

New antiepileptic drugs (AED) and atypical antipsychotics (AAP) as mood stabilizers

The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Angst, J.

How to assess the onset of antidepressant effect: Empirical data on 2788 patients

Time course of response to antidepressant drug treatment: Are there gender differences?

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Annen, B.

Predictive value of sleep EEG markers in long-term course of depression

Antonijevic, I. A.

Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression

Arlt, J.

Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide

Arolt, V.

High basal prolactin values predict response to reboxetine treatment in major depression

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Aschenbrenner, S.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Auer, D. P.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Aust, C.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Auwärter, A.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Bachus, R.

Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol

Bäcker, A.

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Baethge, C.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Baghai, T. C.

Influence of mirtazapine on salivary cortisol in depressed patients

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Gender influence on pharmacogenetic prediction of antidepressive efficacy

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Bahra, R.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Baier, C.

Restaurative therapy for Parkinson’s disease

Bajbouj, M.

EEG source localization during postictal delirium following electroconvulsive therapy

Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Banac, S.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Bandelow, B.

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Barbosa, E.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Barbosa, N. R.

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Barnas, C.

The influence of somatic conditions on benzodiazepine long-term use

Bartels, M.

Treatment of tics in Tourette’s syndrome with aripiprazole

Bartenstein, P.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Barth, U.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Bartl, C.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Bauer, A.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Bauer, M.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Baumann, B.

Effects of antidepressants in postmortem and neuroimaging studies

Baumann, P.

Influence of metabolic processes on course and treatment of opioid-dependence

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.

Baumgart, U.

Rhabdomyolysis associated with olanzapine monotherapy – A case report

Baumgartner, S.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Bayerlein, K.

Leptin plasma levels and craving data during alcohol withdrawal

Craving differs with alcoholic beverages

Bechtel, G.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Leptin levels of alcohol abstainers and detoxification patients are not different

Becker, A.

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Kindling alters rewarding effects of ethanol, morphine and cocaine

Behl, C.

Antioxidants and hormones: Implications for neurodgenerative disorders and aging

Beissbarth, T.

cDNA arrays analyses in an animal model for psychosis-related traits

Bender, S.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Benninghoff, J.

The serotonergic receptor 2C subtype (5-HT2C) regulates survival and proliferation of adult neural stem cells (ANSC) derived from mouse hippocampus

Berendt, F.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Berg, T.

Interferon-alpha treatment and serotonergic dysfunction

Bergemann, N.

Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

Berger, C.

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Berger, M.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine

Modulation of neuropeptidergic circuits

Substance P and substance P antagonists in the pathology and treatment of affective disorders

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Bergmann, A.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Berman, S. M.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Bernhardt, K.

A new concept for crisis management in borderline patients

Bernstein, H. G.

Effects of antidepressants in postmortem and neuroimaging studies

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Bertling, R.

Effectiveness of music therapy on pain reduction and psychopharmacotherapy

Bielau, H.

Effects of antidepressants in postmortem and neuroimaging studies

Bilkei-Gorzo, A.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Binder, E.

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Binder, E. B.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Birg, I. N.

Validation of a genetic mouse model for anxiety and comorbid depression

Analysis of cerebrospinal fluid of depressed patients

Birkenbach-Holdschuh, T.

A new measure of the dopamine challenge by bromocriptine for testing personality

Birkmann, S.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Blaha, L.

Predicting successful job performance of schizophrenics after discharge from hospital

Bleich, S.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Leptin plasma levels and craving data during alcohol withdrawal

Craving differs with alcoholic beverages

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Blennow, K.

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Block, W.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Bodner, T.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Boerner, R. J.

Naturalistic follow-up study of pharmacologic treated patients with anxiety disorders

New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)

Bogerts, B.

Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?

Effects of antidepressants in postmortem and neuroimaging studies

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Boigs, M.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Bokde, A. L. W.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Neural representation of cognitive changes within the visual system in the AD brain

Bölte, S.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Bondy, B.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gender influence on pharmacogenetic prediction of antidepressive efficacy

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

Is there a common basis between psychiatric and somatic diseases

Bonert, A.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Bopp, G.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Borgwardt, S.

Cognitive function and psychomotor performance in schizophrenic patients

Born, C.

Neural representation of cognitive changes within the visual system in the AD brain

Bottino, C. M. C.

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Bottlender, R.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Bozkurt, B.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Brand, S.

Predictive value of sleep EEG markers in long-term course of depression

Braun, H. A.

Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms

Braun, S.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Braus, D.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Braus, D. F.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Brettschneider, S.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Breu, J.

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Brockmöller, J.

Pharmacogenetics based therapeutic recommendations in antidepressant drug therapy

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Bronisch, T.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Brückmann, H.

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Brunner, E.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Brunner, H.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Brunner, J.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Prediction of response to antidepressant monotherapy

Brunnmeier, M.

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Bschor, T.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Bublak, P.

A new diagnostic tool for measuring attentional components in patients with depression

Buchholz, H. G.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Bunck, M.

Validation of a genetic mouse model for anxiety and comorbid depression

Bürger, K.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Burgmair, W.

50 years of chlorpromazine – Serendipity or necessity

Burtscheidt, W.

Alcohol-craving: Therapeutic effects using fMRI

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Bymaster, F.

Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder

Camargo, C. P.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Cannich, A.

The roles of the endogenous cannabinoid system in learning and memory in mice

Carson, W.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Cascorbi, I.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Castro, C. C.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Cerri, G. G.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Cetin, T.

Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Choma, M. E.

Temporal lobe structures by magnetic resonance in schizophrenic patients

Cohrs, S.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Colla, M.

Hippocampal volume reduction and HPA-system activity in major depression

Cordes, J.

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Cumming, P.

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Czekalla, J.

Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)

Czisch, M.

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Członkowska, A.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Członkowski, A.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Dahmen, N.

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Association study of SNPs in G72 and DAAO in schizophrenia

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Dalal, M. A.

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

Dallinger, P.

Gender effects in olanzapine metabolism

Dames, P.

cDNA arrays analyses in an animal model for psychosis-related traits

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Dammann, G.

Leptin levels of alcohol abstainers and detoxification patients are not different

Daniels, C.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

Danker-Hopfe, H.

Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

The significance of non-REM sleep for memory processes in elderly subjects

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Danos, P.

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Däubener, W.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Daumann, J.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Degner, D.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Deiml, T.

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Gender influence on pharmacogenetic prediction of antidepressive efficacy

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

de Jonge, S.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Delini-Stula, A.

Ginkgo biloba in the treatment of antidepressant-induced sexual dysfunction: The results of the Swiss exploratory study in depressed patients

Dettling, M.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Deuschl, G.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

Deuschle, M.

Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations

Circadian blood pressure regulation in hospitalized depressed patients and non-depressed comparison subjects

Steroid synthesis inhibition with ketoconazole and its effect upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans

Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients

Reversible pitch perception shift caused by trimipramine

Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolemia and antidepressant treatment

Hippocampal volume reduction and HPA-system activity in major depression

Deussing, J.

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Dielentheis, T. F.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Dierkes, J.

Leptin levels of alcohol abstainers and detoxification patients are not different

Dierks, T.

Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs

Dietrich, I.

A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits

Dittmann, R. W.

Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder

Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Dobmeier, M.

Subjective response to psychotropic drugs in psychiatric in-patients

Gender effects in olanzapine metabolism

Dobmeier, P.

Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone

Dobrowolny, H.

Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?

Döhnel, K.

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Dong, W.

Neural representation of cognitive changes within the visual system in the AD brain

Dong-Si, T.

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Dragicevic, A.

Therapeutic drug monitoring (TDM) of quetiapine

Costs and effectiveness of therapeutic drug monitoring in psychiatry

Dresel, S.

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Droste, S.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Eap, C. B.

Influence of metabolic processes on course and treatment of opioid-dependence

Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.

Ebenbichler, C.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Ebinger, M.

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls

Results of routine CSF analysis of 1000 psychiatric patients

Ebrecht, M.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Eckermann, G.

Drug interactions in elderly patients

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Eckert, A.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Eckert, K.

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Edlinger, M.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Ehrenreich, H.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Neuroprotection in neuropsychiatric disease

Eich, D.

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Eichhammer, P.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients

Cortical excitability in patients with adult ADHD

Gender effects in olanzapine metabolism

High-frequency transcranial magnetic stimulation in schizophrenia

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Eichinger, M.

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Eichler, O.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Eisensamer, B.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Modulation of ligand-gated ion channels by antidepressants

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Ekrod, K.

Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity

Ella, R.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Gender influence on pharmacogenetic prediction of antidepressive efficacy

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Emir, B.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Engel, R. R.

The repeatable battery for the assessment of neuropsychological status (BRANS) – A useful tool in neuropsychiatry?

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

Systematic screen of serotonergic genes in suicidal behaviour

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Erb, M.

Pharmako-FMRT in Alzheimers dementia

Erdag, S.

A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity

Erfurth, A.

High basal prolactin values predict response to reboxetine treatment in major depression

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Erhardt, A.

Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Is there a genetic continuum between anxiety and depression?

Eschenhagen, T.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Eser, D.

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Gender influence on pharmacogenetic prediction of antidepressive efficacy

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Evans, A. C.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Evers, S.

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Falkai, P.

The impact of pharmacotherapy on the spectra in magnetic resonance spectroscopy

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Faltraco, F.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Neural representation of cognitive changes within the visual system in the AD brain

Fehr, C.

From mouse models to human behavior: Testing candidate genes for alcoholism

Fehsel, K.

In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Fellgiebel, A.

Therapeutic drug monitoring (TDM) of donepezil

Ferrari, U.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Fiebich, B. L.

Modulation of neuropeptidergic circuits

Substance P and substance P antagonists in the pathology and treatment of affective disorders

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Fink, H.

Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats

Finke, K.

A new diagnostic tool for measuring attentional components in patients with depression

Fischer, C. J.

A new model for assessment of mechanisms of behavior control and impulsivity

Fischer-Barnicol, D.

Benefit of modern antipsychotics still withheld from forensic patients

Perazine – the atypical side of an conventional antipsychotic

Fischermann, T.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Fischer-Schulz, C.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Fleischhacker, W. W.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Flor, H.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Folkerts, M.

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Forlenza, O. V.

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons

Forster, S.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Leptin levels of alcohol abstainers and detoxification patients are not different

Förstl, H.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Franc, D.

Results of routine CSF analysis of 1000 psychiatric patients

Frank, E.

Cortical excitability in patients with adult ADHD

Franke, E.

Interferon-alpha treatment and serotonergic dysfunction

Franke, L.

Cognitive function and psychomotor performance in schizophrenic patients

Franz, M.

Subjective reactions to neuroleptic treatment: Prediction of compliance?

Freudenmann, R. W.

Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system

Frick, A.

Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

Frieboes, R. M.

Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression

Friege, L.

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

A new concept for crisis management in borderline patients

Friess, E.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

Fritzer, G.

A new model for assessment of mechanisms of behavior control and impulsivity

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Frodl, T.

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Frommann, I.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Frye, M. A.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Fuchs, B.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Fuchsberger, T.

Neural representation of cognitive changes within the visual system in the AD brain

Gaebel, W.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Alcohol-craving: Therapeutic effects using fMRI

Gaertner, I.

TDM of psychoactive medication in the risk patient

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Gallhofer, B.

Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Subjective reactions to neuroleptic treatment: Prediction of compliance?

Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Gallinat, J.

EEG source localization during postictal delirium following electroconvulsive therapy

Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Galwas, C.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Gamma, A.

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Garziella, M.

New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)

Gastpar, M.

Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity

Gattaz, W. F.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons

Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing

Gebhardt, S.

Genetic aspects of antipsychotic induced body weight change

Genius, J. J. K.

Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy

Gerlach, M.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Gerok-Falke, K.

A new concept for crisis management in borderline patients

Gertz, H. J.

Pharmacotherapeutic options in vascular dementia

Gescher, D.

Megestrol attenuates hormonal response to CCK-4

Gesierich, T.

Effective connectivity and pharmacological modulation in schizophrenia

Geyer, M. A.

Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients

Giegling, I.

A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Systematic screen of serotonergic genes in suicidal behaviour

Association study of SNPs in G72 and DAAO in schizophrenia

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

cDNA arrays analyses in an animal model for psychosis-related traits

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Giesler, M.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Gilg, T.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Gilling, K.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gimpl, G.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gjedde, A.

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Glatz, D.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Göbel, C.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Godemann, F.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Göder, R.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Goedecken, B.

Megestrol attenuates hormonal response to CCK-4

Goldman, D.

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Gonnermann, C.

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Gouzoulis-Mayfrank, E.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Grauer, M. T.

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls

Results of routine CSF analysis of 1000 psychiatric patients

Graz, C.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Grecksch, G.

Kindling alters rewarding effects of ethanol, morphine and cocaine

Greetfeld, M.

Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation

Grimm, C.

Genetic variants influencing retinal degeneration and neuroprotection in the eye

Grodd, W.

Pharmako-FMRT in Alzheimers dementia

Grohmann, R.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Groß, W.

Predicting successful job performance of schizophrenics after discharge from hospital

Gruesser, S. M.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Gründer, G.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Therapeutic drug monitoring of ziprasidone

Grunewald, R. W.

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Grunze, H.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Treatment of bipolar depression

Gruppe, H.

Subjective reactions to neuroleptic treatment: Prediction of compliance?

Guan, Z.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Haack, M.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Early prediction of changes in weight during six weeks of treatment with antidepressants

Haag, A.

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Haass, C.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Habel, U.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Haberger, C.

A new diagnostic tool for measuring attentional components in patients with depression

Haberhausen, M.

Genetic aspects of antipsychotic induced body weight change

Habersetzer, U.

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Habrat, B.

Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?

Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse

Haen, E.

Benefit of modern antipsychotics still withheld from forensic patients

Perazine – the atypical side of an conventional antipsychotic

Psychopharmacotherapy and adverse drug effects in old age psychiatry

Gender effects in olanzapine metabolism

Changes in the effectiveness of drugs in elderly people

Hagemeyer, T. P.

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Hagen, T.

Hippocampal volume reduction and HPA-system activity in major depression

Hagenhoff, M.

Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients

Hahn, K.

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Hahn, R.

Multimorbidity in the elderly in a geriatric hospital

Hajak, G.

Benefit of modern antipsychotics still withheld from forensic patients

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Perazine – the atypical side of an conventional antipsychotic

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients

Cortical excitability in patients with adult ADHD

Gender effects in olanzapine metabolism

High-frequency transcranial magnetic stimulation in schizophrenia

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Hamann, J.

Language Bias in Neuroscience – Is the Tower of Babel located in Germany?

Psychotropic polypharmacy. An analysis of a large outpatient prescription database

Hamark, L.

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Hamke, M.

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Hammel, S.

Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system

Hampel, H.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Phosphorylated tau protein as a core biomarker of Alzheimer’s disease

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Neural representation of cognitive changes within the visual system in the AD brain

Hanewald, B.

Subjective reactions to neuroleptic treatment: Prediction of compliance?

Hanisch, M.

Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Hapfelmeier, G.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Hartmann, A. M.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Association study of SNPs in G72 and DAAO in schizophrenia

cDNA arrays analyses in an animal model for psychosis-related traits

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Härtter, S.

P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride

Therapeutic drug monitoring (TDM) of quetiapine

Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?

Costs and effectiveness of therapeutic drug monitoring in psychiatry

Therapeutic drug monitoring of ziprasidone

Haseneder, R.

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Hatzinger, M.

Predictive value of sleep EEG markers in long-term course of depression

GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression

Hauke, W.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Havemann-Reinecke, U.

Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity

Hebebrand, J.

Genetic aspects of antipsychotic induced body weight change

Hegerl, U.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients

Heimberg, E.

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Heindl, B.

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Heinz, A.

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Relapse and gender specific activation of the striatum in alcohol dependent patients

Heinzel-Gutenbrunner, M.

Genetic aspects of antipsychotic induced body weight change

Held, K.

Nocturnal ghrelin levels in normal controls – effects of gender

Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium

Ghrelin promotes slow-wave sleep in man

GHRH impairs sleep in normal females

Hellweg, R.

Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Hemmer, B.

Cytoimmunological changes and treatment response in major depression

Hemmeter, U.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Predictive value of sleep EEG markers in long-term course of depression

GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Henkel, V.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Henn, F. A.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Hennig, J.

A new measure of the dopamine challenge by bromocriptine for testing personality

Influence of mirtazapine on salivary cortisol in depressed patients

Henniger, M. S. H.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Choosing the right black mice – a matter of particular importance!

Henning, U.

In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils

Proteomics reveals differential protein regulation in human glioma cells by imipramine

In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Transport of clozapine and its major metabolites into human cells of glial and neuronal origin

Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs

Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Heppekausen, K.

Is premature termination of opiate detoxification due to intensive withdrawal or craving?

Heres, S.

Language Bias in Neuroscience – Is the Tower of Babel located in Germany?

Hermann, D.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Hermann, H.

The roles of the endogenous cannabinoid system in learning and memory in mice

Herpfer, I.

Modulation of neuropeptidergic circuits

Substance P and substance P antagonists in the pathology and treatment of affective disorders

Herr, A. S.

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

Herr, R.

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Hesse, A.

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Hesse, A. C.

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Hetzel, G.

High basal prolactin values predict response to reboxetine treatment in major depression

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Heuser, I.

Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis

Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients

The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)

The significance of non-REM sleep for memory processes in elderly subjects

Hippocampal volume reduction and HPA-system activity in major depression

Hiemke, C.

P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride

Therapeutic drug monitoring (TDM) of quetiapine

Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?

Therapeutic drug monitoring (TDM) of donepezil

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Costs and effectiveness of therapeutic drug monitoring in psychiatry

Therapeutic drug monitoring of ziprasidone

Hillemacher, T.

Craving differs with alcoholic beverages

Himmerich, H.

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain

Early prediction of changes in weight during six weeks of treatment with antidepressants

Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

Epidemiology and mechanisms of weight gain induced by psychotropic drugs

Hinze-Selch, D.

Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)

A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity

Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Effect of antipsychotics on microglia in vitro

Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression

Hirsch, J.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Hobusch, K.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Hoefgen, B.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Hofer, A.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Höger, C.

Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity

Höhne, T.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Höllt, V.

The mu opioid receptor: Molecular and functional aspects

Holsboer, F.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Neuropsychological deficits and long-term outcomes in patients with affective disorders

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

The effects of RS-86 on sleep with respect to depression and HLA-type

The youth hormone DHEA: A benefit for pathologic sleep alterations?

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

Role of chaperones in signal transduction of the glucocorticoid receptor

A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation

Analysis of cerebrospinal fluid of depressed patients

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Prediction of response to antidepressant monotherapy

Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Is there a genetic continuum between anxiety and depression?

Holsboer-Trachsler, E.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Predictive value of sleep EEG markers in long-term course of depression

GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression

Ginkgo biloba in the treatment of antidepressant-induced sexual dysfunction: The results of the Swiss exploratory study in depressed patients

Holzner, B.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Hornung, O. P.

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

The significance of non-REM sleep for memory processes in elderly subjects

Horrobin, D.

Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression

Huber, J.

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Huber, M. T.

Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms

Huber, P.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Leptin levels of alcohol abstainers and detoxification patients are not different

Huchzermeier, C.

Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)

Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression

Huebner-Liebermann, B.

Antidepressants from an internet-patients’ viewpoint

Hüll, M.

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells

Hummer, M.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Hunsche, S.

Effective connectivity and pharmacological modulation in schizophrenia

Ibach, B.

Psychopharmacotherapy and adverse drug effects in old age psychiatry

Impler, E. M.

Association study of SNPs in G72 and DAAO in schizophrenia

Ising, M.

Nocturnal ghrelin levels in normal controls – effects of gender

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Ghrelin promotes slow-wave sleep in man

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

The effects of RS-86 on sleep with respect to depression and HLA-type

Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia

Prediction of response to antidepressant monotherapy

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Is there a genetic continuum between anxiety and depression?

Jachau, K.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Jacob, A.

Analysis of cerebrospinal fluid of depressed patients

Jacob, W.

Validation of a genetic mouse model for anxiety and comorbid depression

Jacobi, F.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Jäger, L.

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Jäger, M.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Jahn, H.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Gender effects in pharmacological relapse prevention of alcoholism

Megestrol attenuates hormonal response to CCK-4

Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide

Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors

Jahn, T.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Jakob, F.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Janssen, B.

How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?

Subjective quality of life and treatment strategies in schizophrenia outpatient care

Cost effectiveness of different treatment strategies in schizophrenia outpatient care

Jaquenoud-Sirot, E.

Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.

Jockers-Scherübl, M. C.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Johann, M.

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Jordan, W.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Juckel, G.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients

Kalisch, R.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

Kamprath, K.

The roles of the endogenous cannabinoid system in learning and memory in mice

Kapfhammer, H. P.

Treatment of depression with antidepressant medications in patients with cardiovascular disease

Karow, A.

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Kastrup, A.

Treatment of tics in Tourette’s syndrome with aripiprazole

Kaufmann, B.

Effective connectivity and pharmacological modulation in schizophrenia

Kaufmann, C.

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain

Early prediction of changes in weight during six weeks of treatment with antidepressants

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Keck, M. E.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Is there a genetic continuum between anxiety and depression?

Keil, U.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Kell, S.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Effect of antipsychotics on microglia in vitro

Kellermann, T.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Kellner, M.

Megestrol attenuates hormonal response to CCK-4

Kemmler, G.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Alterations of glucose metabolism under treatment with atypical antipsychotics

Kerchlango, A.

Psychopharmacotherapy and adverse drug effects in old age psychiatry

Kern, N.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Keßler, M.

Validation of a genetic mouse model for anxiety and comorbid depression

Kiefer, F.

Gender effects in pharmacological relapse prevention of alcoholism

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Kießlinger, U.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Kircher, T.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Pharmako-FMRT in Alzheimers dementia

Kirchheiner, J.

Pharmacogenetics based therapeutic recommendations in antidepressant drug therapy

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Kirchner, H.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Kirner, A.

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

Long term electroconvulsive treatment as maintenance and prophylactic therapy of affective disorders

Kirschbaum, C.

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Kissling, W.

How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?

Subjective quality of life and treatment strategies in schizophrenia outpatient care

Cost effectiveness of different treatment strategies in schizophrenia outpatient care

Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life

Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention

Language Bias in Neuroscience – Is the Tower of Babel located in Germany?

Psychotropic polypharmacy. An analysis of a large outpatient prescription database

Klein, H. E.

Benefit of modern antipsychotics still withheld from forensic patients

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Subjective response to psychotropic drugs in psychiatric in-patients

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Perazine – the atypical side of an conventional antipsychotic

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Psychopharmacotherapy and adverse drug effects in old age psychiatry

Antidepressants from an internet-patients’ viewpoint

Klein, M.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Klein, S.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Kleinlogel, H.

Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs

Klieser, E.

Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?

Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study

Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

Effectiveness of music therapy on pain reduction and psychopharmacotherapy

Klimke, A.

In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils

Proteomics reveals differential protein regulation in human glioma cells by imipramine

In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Transport of clozapine and its major metabolites into human cells of glial and neuronal origin

Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs

Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Knolle-Veentjer, S.

A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity

Koch, J. M.

Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)

Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor

Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression

Koch, W.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Koerner, C.

Reversible pitch perception shift caused by trimipramine

Koethe, D.

Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

Kohl, C.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Köhnlein, O.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Kopf, D.

Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolemia and antidepressant treatment

Kopitz, J.

Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

Kornhuber, J.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Craving differs with alcoholic beverages

Kostorz, L.

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Kotter, G.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Kraft, E.

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Krampe, H.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Kraus, T.

Leptin plasma levels and craving data during alcohol withdrawal

Epidemiology and mechanisms of weight gain induced by psychotropic drugs

Krausz, M.

Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)

Krell, D.

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Kress, K. R.

Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

Krieg, J. C.

Cytoimmunological changes and treatment response in major depression

Cytokines, the regulation of body weight and psychopharmacological treatment

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Genetic aspects of antipsychotic induced body weight change

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Krieger, K.

In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils

Proteomics reveals differential protein regulation in human glioma cells by imipramine

In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Transport of clozapine and its major metabolites into human cells of glial and neuronal origin

Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs

Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin

Krieger, S.

Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Krömer, S. A.

Validation of a genetic mouse model for anxiety and comorbid depression

Kromolan, B.

Craving differs with alcoholic beverages

Kronenberg, G.

Hippocampal volume reduction and HPA-system activity in major depression

Kronenwett, R.

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Kröner-Herwig, B.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Kropp, S.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Kuenzel, H. E.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Kuhn, H. G.

Adult neurogenesis

Kuhn, K.

Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone

Kühn, K. U.

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride

Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls

Kungel, M.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Künzel, H. E.

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Kuss, H. J.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Laakmann, G.

Influence of mirtazapine on salivary cortisol in depressed patients

LaFougere, G.

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Lammers, C. H.

Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder

Lancel, M.

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

The youth hormone DHEA: A benefit for pathologic sleep alterations?

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

Landgraf, R.

Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP

Validation of a genetic mouse model for anxiety and comorbid depression

Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Lang, U. E.

Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Lange, K. W.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Lange-Asschenfeld, C.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Langguth, B.

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients

Cortical excitability in patients with adult ADHD

High-frequency transcranial magnetic stimulation in schizophrenia

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Lanquillon, S.

Benefit of modern antipsychotics still withheld from forensic patients

Perazine – the atypical side of an conventional antipsychotic

Lauer, C.

The effects of RS-86 on sleep with respect to depression and HLA-type

Laufkötter, R.

Cortical excitability in patients with adult ADHD

Laux, G.

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Lechleitner, M.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Lederbogen, F.

Circadian blood pressure regulation in hospitalized depressed patients and non-depressed comparison subjects

Lehmann, A.

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Lehner, M.

Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?

Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse

Leicht, G.

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Leinsinger, G.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Neural representation of cognitive changes within the visual system in the AD brain

Lemke, M. R.

A new model for assessment of mechanisms of behavior control and impulsivity

Lemmer, W.

Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?

Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study

Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

Effectiveness of music therapy on pain reduction and psychopharmacotherapy

Lenoci, M.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Lenzen, K.

From mouse models to human behavior: Testing candidate genes for alcoholism

Leube, D.

Pharmako-FMRT in Alzheimers dementia

Leucht, S.

Language Bias in Neuroscience – Is the Tower of Babel located in Germany?

Lewczuk, P.

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Lewitzka, U.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Lichtner, P.

Evidence for genetic heterogeneity in Restless Legs Syndrome

Lichy, C.

Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy

Lieb, K.

Modulation of neuropeptidergic circuits

Substance P and substance P antagonists in the pathology and treatment of affective disorders

Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder

Linka, T.

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Lis, S.

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Lochmann, M.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Loeffler, S.

In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils

Increased sensitivity of isolated CD34+ cells towards clozapine-treatment

Transport of clozapine and its major metabolites into human cells of glial and neuronal origin

Lojewski, I.

Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity

London, E. D.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Lopez-Bayo, P.

Neural representation of cognitive changes within the visual system in the AD brain

Lorberg, C.

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Lucae, S.

Is there a genetic continuum between anxiety and depression?

Ludewig, K.

Different aspects of executive function in first episode schizophrenia

Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients

Ludewig, S.

Different aspects of executive function in first episode schizophrenia

Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients

Lujic, C.

A new measure of the dopamine challenge by bromocriptine for testing personality

Lunkenheimer, J.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Lutz, B.

The roles of the endogenous cannabinoid system in learning and memory in mice

Lutz, R.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Maccarrone, G.

Analysis of cerebrospinal fluid of depressed patients

Mager, T.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Mahlberg, R.

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Mahlke, K.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Maier, W.

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride

Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Pharmacogenetic methods for rational drug choice

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Majer, M.

Neuropsychological deficits and long-term outcomes in patients with affective disorders

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Maler, M.

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Mann, K.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Relapse and gender specific activation of the striatum in alcohol dependent patients

Marcus, R.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Marmar, C. R.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Marocco, J.

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Marques, C. A.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Marsicano, G.

The roles of the endogenous cannabinoid system in learning and memory in mice

Martin, M.

Genetic aspects of antipsychotic induced body weight change

Martin, P.

Different aspects of executive function in first episode schizophrenia

Mass, R.

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Mathias, S.

Nocturnal ghrelin levels in normal controls – effects of gender

Ghrelin promotes slow-wave sleep in man

Modulation of GABAergic systems with GABA agonists and antagonists, effects on sleep EEG and hormone secretion

GHRH impairs sleep in normal females

Matthies, U.

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Maurer, C.

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Mavrogiorgou, P.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Mayer, G.

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Mazziotta, J. C.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Meichel, K.

Hippocampal volume reduction and HPA-system activity in major depression

Meier, A.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Meisenzahl, E. M.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Meitinger, T.

Evidence for genetic heterogeneity in Restless Legs Syndrome

Mendes, C. T.

Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons

Meraner, V.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Mergl, R.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients

Messer, T.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Metten, M.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Metzler, T. J.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Meyer-Lindenberg, A.

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Michael, N.

High basal prolactin values predict response to reboxetine treatment in major depression

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Michel, K.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Michelson, D.

Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder

Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder

Milfay, D.

Validation of a genetic mouse model for anxiety and comorbid depression

Minov, C.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Mirowska, D.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Missler, U.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Mobascher, A.

Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs

Modell, S.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Neuropsychological deficits and long-term outcomes in patients with affective disorders

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

The effects of RS-86 on sleep with respect to depression and HLA-type

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Moeller, O.

High basal prolactin values predict response to reboxetine treatment in major depression

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Moller, H. J.

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

Möller, H. J.

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients

A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Systematic screen of serotonergic genes in suicidal behaviour

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Association study of SNPs in G72 and DAAO in schizophrenia

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Neural representation of cognitive changes within the visual system in the AD brain

Möller-Hartmann, W.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Monory, K.

The roles of the endogenous cannabinoid system in learning and memory in mice

Morgenthaler, N.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Mossiaguine, I.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Mössner, R.

An organic cation transporter capable of transporting serotonin is upregulated in serotonin transporter-deficient mice

Mueller-Oerlinghausen, B.

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Mulert, C.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Müller, B. W.

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Müller, J.

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Müller, J. L.

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Müller, K. M.

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Müller, M. B.

Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Müller, M. J.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Therapeutic drug monitoring (TDM) of quetiapine

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Müller, W. E.

Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity

Activation of nonselective cation channels by hyperforin – A novel mechanism of antidepressant activity

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Müller-Myhsok, B.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Evidence for genetic heterogeneity in Restless Legs Syndrome

Is there a genetic continuum between anxiety and depression?

Müller-Oerlinghausen, B.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Müller-Siecheneder, F.

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Long term electroconvulsive treatment as maintenance and prophylactic therapy of affective disorders

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Müller-Spahn, F.

Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol

Murck, H.

Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression

Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium

Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract

Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression

Murgatroyd, C.

Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP

Naber, D.

Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Namendorf, C.

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls

Netter, P.

A new measure of the dopamine challenge by bromocriptine for testing personality

Neu, P.

The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers

Neuhaus, A.

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Neuhaus, A. H.

EEG source localization during postictal delirium following electroconvulsive therapy

Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)

Neumeier, K.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Neylan, T. C.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Nickel, T.

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Niedmann, P.

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Nietmann, P. D.

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Nissen, C.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine

Normann, C.

Modulation of Ca2+ currents and long-term synaptic plasticity by SSRIs

Norra, C.

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Novick, D.

Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Nuernberger, P.

From mouse models to human behavior: Testing candidate genes for alcoholism

Nunes, P. V.

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Nyhuis, P. W.

Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity

Oehl, M. A.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Ogel, N.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Ohl, F.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Refinement of inbred mouse strains as animal models for psychiatric disorders

Influence of circadian factors on behavioral and cognitive testing in mice

Ometto, M.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Opgen-Rhein, C.

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

Ostermeier, C. P.

Subjective response to psychotropic drugs in psychiatric in-patients

Otte, C.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Ottomeyer, C.

Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells

Padberg, F.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Panhuysen, M.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Parsons, C.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Pechler, S.

Neural representation of cognitive changes within the visual system in the AD brain

Pedrosa Gil, F.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Penzel, T.

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Perfahl, M.

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Peters, M.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Petersen, I.

Effect of antipsychotics on microglia in vitro

Pfeiff, L.

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Pfennig, A.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?

Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Prediction of response to antidepressant monotherapy

Is there a genetic continuum between anxiety and depression?

Pfister, H.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Philipsen, X.

Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder

Pich, M.

Interferon-alpha treatment and serotonergic dysfunction

Pitschel-Walz, G.

Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life

Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention

Plewnia, C.

Treatment of tics in Tourette’s syndrome with aripiprazole

Plodeck, V.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Pogarell, O.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Pohlmann, K.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Pollmächer, T.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Influence of sleep deprivation on plasma ghrelin levels in healthy subjects

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain

Early prediction of changes in weight during six weeks of treatment with antidepressants

Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

Epidemiology and mechanisms of weight gain induced by psychotropic drugs

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Ponath, G.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Pöpperl, G.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Poser, W.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Poustka, F.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Pragst, F.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Preuss, U. W.

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Pridzun, L.

Leptin levels of alcohol abstainers and detoxification patients are not different

Priebe, M.

Alcohol-craving: Therapeutic effects using fMRI

Propp, S.

Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI

Pruessner, J. C.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Pugner, K.

Psychotropic polypharmacy. An analysis of a large outpatient prescription database

Putzhammer, A.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Quednow, B. B.

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride

Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls

Racz, I.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Räder, H.

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Raedler, T.

Gender effects in pharmacological relapse prevention of alcoholism

Megestrol attenuates hormonal response to CCK-4

Sex-specific differences in pain-induced facial muscle activation

Rammes, G.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Rao, M. L.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Rapoport, S. I.

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

Rapp, A.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Rasgon, N.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Rau, T.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Reckemeyer, I.

Cytoimmunological changes and treatment response in major depression

Regen, F.

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

The significance of non-REM sleep for memory processes in elderly subjects

Regenbogen, B.

Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?

Reiff, J.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

Rein, T.

The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis

FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

Role of chaperones in signal transduction of the glucocorticoid receptor

A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation

Reinbacher, A.

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Reinhold, J.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Reischies, F. M.

EEG source localization during postictal delirium following electroconvulsive therapy

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Reischle, E.

Perazine – the atypical side of an conventional antipsychotic

Reiser, M.

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Remé, C. E.

Genetic variants influencing retinal degeneration and neuroprotection in the eye

Remschmidt, H.

Genetic aspects of antipsychotic induced body weight change

Renders, L.

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Reul, J. H. M. H.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Reulbach, U.

Leptin plasma levels and craving data during alcohol withdrawal

Reuter, M.

A new measure of the dopamine challenge by bromocriptine for testing personality

Rex, A.

Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats

Richter, A.

Predicting successful job performance of schizophrenics after discharge from hospital

Rickel, S.

Results of routine CSF analysis of 1000 psychiatric patients

Riederer, P.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Riemann, D.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine

Rippel, A.

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls

Rist, F.

Is premature termination of opiate detoxification due to intensive withdrawal or craving?

Ritzhaupt, A.

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Rocamora, R.

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Rödel, A.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Influence of circadian factors on behavioral and cognitive testing in mice

Rodenbeck, A.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Roesch, F.

Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study

Röhling, K.

A new concept for crisis management in borderline patients

Romeo, E.

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

Roots, I.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Röpke, S.

Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis

Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Rosenhagen, M.

The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis

Role of chaperones in signal transduction of the glucocorticoid receptor

Analysis of cerebrospinal fluid of depressed patients

Rössler, W.

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Rothenberger, A.

Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity

Rothenhäusler, H. B.

Treatment of depression with antidepressant medications in patients with cardiovascular disease

Rothermundt, M.

The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients

Visually-evoked event-related potentials and oral citalopram challenge test

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Rudolf, S.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Rüegg, J.

A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation

Rufer, D.

Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol

Ruhrmann, S.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Rujescu, D.

A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits

Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Systematic screen of serotonergic genes in suicidal behaviour

Association study of SNPs in G72 and DAAO in schizophrenia

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

cDNA arrays analyses in an animal model for psychosis-related traits

Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Rummel, C.

Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life

Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention

Ruppert, A.

Psychotropic polypharmacy. An analysis of a large outpatient prescription database

Rupprecht, R.

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gender influence on pharmacogenetic prediction of antidepressive efficacy

Modulation of ligand-gated ion channels by antidepressants

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Rüther, E.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition

Quetiapine improves sleep quality in healthy subjects

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Sachse, C.

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Sachse, J.

Therapeutic drug monitoring (TDM) of quetiapine

Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?

Therapeutic drug monitoring (TDM) of donepezil

Costs and effectiveness of therapeutic drug monitoring in psychiatry

Therapeutic drug monitoring of ziprasidone

Samadi, P.

Effect of antipsychotics on microglia in vitro

Sand, P.

Gender effects in olanzapine metabolism

Sander, T.

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

From mouse models to human behavior: Testing candidate genes for alcoholism

Sartor, H.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Sartory, G.

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Sasse, J.

Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Sauer, H.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Savaskan, E.

Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol

Schaefer, M.

Interferon-alpha treatment and serotonergic dysfunction

Schaeffer, E. L.

Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons

Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing

Schafer, M.

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

Schapiro, M. B.

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

Schaub, R.

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Scherb, C.

Effective connectivity and pharmacological modulation in schizophrenia

Scherbaum, N.

Is premature termination of opiate detoxification due to intensive withdrawal or craving?

Scherer, J.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone

Scheurich, A.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Schewe, H. J.

Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol

Schick, M.

Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors

Schickert, R.

Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats

Schiffelholz, T.

Novel object presentation affects sleep-wake behavior in rats

Perinatal, subchronic NMDA receptor antagonism attenuates behavior from childhood to adulthood in rats

The youth hormone DHEA: A benefit for pathologic sleep alterations?

Schild, H.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Schildberg, F.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Schillen, T.

Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Schindehütte, J.

Restaurative therapy for Parkinson’s disease

Schindler, F.

The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Schlattmann, P.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Schlösser, R.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Effective connectivity and pharmacological modulation in schizophrenia

Schlotter, W.

Treatment of tics in Tourette’s syndrome with aripiprazole

Schmaus, W.

Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone

Schmauß, M.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Schmid, D. A.

Nocturnal ghrelin levels in normal controls – effects of gender

Ghrelin promotes slow-wave sleep in man

Schmid, R.

Rhabdomyolysis associated with olanzapine monotherapy – A case report

Schmidt, L. G.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP

From mouse models to human behavior: Testing candidate genes for alcoholism

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Therapeutic drug monitoring (TDM) of donepezil

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Schmidt, U.

The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis

FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain

Role of chaperones in signal transduction of the glucocorticoid receptor

Schmidt, W.

Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal

Schmitt, A.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

An organic cation transporter capable of transporting serotonin is upregulated in serotonin transporter-deficient mice

Schmitt, G. J. E.

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Schmitt, U.

P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride

Schmitz, M.

Kindling alters rewarding effects of ethanol, morphine and cocaine

Schneider, F.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Alcohol-craving: Therapeutic effects using fMRI

Schneider, W.

A new diagnostic tool for measuring attentional components in patients with depression

Schnitker, R.

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Schöchlin, C.

The repeatable battery for the assessment of neuropsychological status (BRANS) – A useful tool in neuropsychiatry?

Scholer, A.

Leptin levels of alcohol abstainers and detoxification patients are not different

Schommer, N. C.

Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis

Schorr, C.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Schreckenberger, M.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Schredl, M.

Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?

Schreiber, W.

Predicting successful job performance of schizophrenics after discharge from hospital

Schreiber, Y. A.

Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia

Schreqdl, M.

The significance of non-REM sleep for memory processes in elderly subjects

Schröder, C.

Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol

Schröter, A.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Schubert, M. I.

Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla

Schuld, A.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study

Influence of sleep deprivation on plasma ghrelin levels in healthy subjects

Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain

Early prediction of changes in weight during six weeks of treatment with antidepressants

Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

Schüle, C.

Influence of mirtazapine on salivary cortisol in depressed patients

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Gender influence on pharmacogenetic prediction of antidepressive efficacy

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Schulz, C.

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease

Schüssler, P.

Nocturnal ghrelin levels in normal controls – effects of gender

GHRH impairs sleep in normal females

Schütz, C. G.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Schwab, S.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Schwaiger, M.

Interferon-alpha treatment and serotonergic dysfunction

Schwarz, C.

How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?

Subjective quality of life and treatment strategies in schizophrenia outpatient care

Cost effectiveness of different treatment strategies in schizophrenia outpatient care

Schwegler, H.

Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?

Schwertfeger, N.

The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers

Seemann, U.

How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?

Subjective quality of life and treatment strategies in schizophrenia outpatient care

Cost effectiveness of different treatment strategies in schizophrenia outpatient care

Seidl, S.

Leptin levels of alcohol abstainers and detoxification patients are not different

Seifritz, E.

GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression

Selig, F.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Shah, N. J.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Alcohol-craving: Therapeutic effects using fMRI

Shapa, M.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Siegmund, A.

A new measure of the dopamine challenge by bromocriptine for testing personality

Siessmeier, T.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Sillaber, I.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Choosing the right black mice – a matter of particular importance!

Singer, A.

Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity

Singewald, N.

Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract

Sinner, C.

Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract

Sirén, A. L.

Neuroprotection in neuropsychiatric disease

Skerstupeit, M.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Skipper, G.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Smesny, S.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Smirnov, A.

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Smolka, M.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Sommer, M.

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Song, C.

Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression

Sonntag, A.

Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia

Spengler, D.

Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP

Sperling, W.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Craving differs with alcoholic beverages

Spernal, J.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Sperner-Unterweger, B.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Spießl, H.

Subjective response to psychotropic drugs in psychiatric in-patients

Antidepressants from an internet-patients’ viewpoint

Rhabdomyolysis associated with olanzapine monotherapy – A case report

Spitzer, M.

Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system

Stamm, T.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Stassen, H. H.

How to assess the onset of antidepressant effect: Empirical data on 2788 patients

Time course of response to antidepressant drug treatment: Are there gender differences?

Oligogenic approaches to modelling onset of action of antidepressants

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Stauch, R.

The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Stawicki, S.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Stecker, G.

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Steiger, A.

Nocturnal ghrelin levels in normal controls – effects of gender

Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium

Ghrelin promotes slow-wave sleep in man

Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression

GHRH impairs sleep in normal females

Steiner, B.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Steinlein, O. K.

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

Stengel, M.

Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor

Sterr, A.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline

Stoecker, T.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Stoeter, P.

Effective connectivity and pharmacological modulation in schizophrenia

Stohler, R.

Pharmacodynamic and -kinetic properties of heroin in maintenance treatment for opioid dependence

Storch, C.

Influence of circadian factors on behavioral and cognitive testing in mice

Ströhle, A.

Anxiolytic activity of atrial natriuretic peptide (ANP)

GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety

Strom, T. M.

Evidence for genetic heterogeneity in Restless Legs Syndrome

Szafrański, T.

Polish version of Medication Adherence Rating Scale (MARS)

Smoking in schizophrenia –Relationship to psychopathology and side-effects

Szegedi, A.

How to assess the onset of antidepressant effect: Empirical data on 2788 patients

Time course of response to antidepressant drug treatment: Are there gender differences?

Oligogenic approaches to modelling onset of action of antidepressants

From mouse models to human behavior: Testing candidate genes for alcoholism

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Tadic, A.

From mouse models to human behavior: Testing candidate genes for alcoholism

Talib, L. L.

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Taracha, E.

Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?

Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse

Tatsch, K.

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants

Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Tavares Jr, H.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Teipel, S.

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Teipel, S. J.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Neural representation of cognitive changes within the visual system in the AD brain

Theisen, F. M.

Genetic aspects of antipsychotic induced body weight change

Theuring, F.

Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors

Thron, A.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Thum, A.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Thürauf, N.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Toll, C.

A new measure of the dopamine challenge by bromocriptine for testing personality

Träber, F.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Treffurth, Y.

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Treiber, K.

Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity

Tremblay, P.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Trenkwalder, C.

Restaurative therapy for Parkinson’s disease

Evidence for genetic heterogeneity in Restless Legs Syndrome

Tsolakidou, A.

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

Tucha, O.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Turck, C. W.

Validation of a genetic mouse model for anxiety and comorbid depression

Analysis of cerebrospinal fluid of depressed patients

Uebelhack, R.

Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol

Interferon-alpha treatment and serotonergic dysfunction

Cognitive function and psychomotor performance in schizophrenic patients

Ufer, S.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Uhr, M.

Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression

Antidepressive drugs as substrates of P-glycoprotein at the blood brain barrier

Influence of sleep deprivation on plasma ghrelin levels in healthy subjects

Nocturnal ghrelin levels in normal controls – effects of gender

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls

Ghrelin promotes slow-wave sleep in man

Results of routine CSF analysis of 1000 psychiatric patients

Analysis of cerebrospinal fluid of depressed patients

Ulferts, J.

Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients

Ullrich, H.

Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?

Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study

Ulrich, S.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Urbanek, C.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis

The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT

Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

van Boemmel, F.

Interferon-alpha treatment and serotonergic dysfunction

van Calker, D.

Adenosinergic mechanisms in the brain: Potential targets for the treatment of mood disorders?

Mechanism of action of mood stabilizers

Varga, A.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Vedder, H.

Cytoimmunological changes and treatment response in major depression

Cytokines, the regulation of body weight and psychopharmacological treatment

Vernaleken, I.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Viviani, R.

Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system

Voderholzer, U.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine

Vogel, M.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany

Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Vogel, T.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Volkmann, J.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

von Kleinsorgen, M.

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Vucurevic, G.

Effective connectivity and pharmacological modulation in schizophrenia

v Widdern, O.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Wacker, P.

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex

Wagner, M.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride

Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Wagner, P.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia

Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia

Efficacy of aripiprazole in the treatment of mania

Wagner, T.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Walcher, J.

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Warnecke, M.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Weber, A.

Cytokines, the regulation of body weight and psychopharmacological treatment

Weber, E. H.

Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease

Weber, F.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Weber, M.

Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome

Weber, M. M.

50 years of chlorpromazine – Serendipity or necessity

Weber, T.

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Wehrle, R.

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Weikel, J. C.

Nocturnal ghrelin levels in normal controls – effects of gender

Ghrelin promotes slow-wave sleep in man

GHRH impairs sleep in normal females

Weinhold, N.

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Weinmann, W.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Weiser, C.

Results of routine CSF analysis of 1000 psychiatric patients

Weißenbacher, P.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders

Refinement of inbred mouse strains as animal models for psychiatric disorders

Weller, L.

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Welt, T.

Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal

Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism

Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Wendicke, K.

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Wenzel, A.

Genetic variants influencing retinal degeneration and neuroprotection in the eye

Wernicke, J.

Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder

Westheide, J.

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride

Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls

Wetter, T. C.

Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study

Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study

Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study

Weyh, T.

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Whybrow, P. C.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Wicha, W.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Wichniak, A.

Ghrelin promotes slow-wave sleep in man

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Wiedemann, K.

Gender effects in pharmacological relapse prevention of alcoholism

Megestrol attenuates hormonal response to CCK-4

Sex-specific differences in pain-induced facial muscle activation

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide

Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors

Wiesbeck, G.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Wiesmann, M.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Wiesmüller, M.

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Wigger, A.

Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP

Validation of a genetic mouse model for anxiety and comorbid depression

Wilhelm, J.

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Willmroth, F.

Adenosinergic mechanisms in the brain: Potential targets for the treatment of mood disorders?

Mechanism of action of mood stabilizers

Wilms, S.

A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Wiltfang, J.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Winkelmann, J.

Evidence for genetic heterogeneity in Restless Legs Syndrome

Winterer, G.

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Cortical signal-to-noise ratio: Prefrontal pathophysiology and genetics of schizophrenia – A two-center study in Bethesda (USA) and Berlin (Germany)

Wirtz, G.

Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs

Wirz-Justice, A.

Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol

Wismann, B.

Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity

Witcher, J.

Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder

Witt, K.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

Wittchen, H. U.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Wochnik, G. M.

FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain

Role of chaperones in signal transduction of the glucocorticoid receptor

Wodarz, N.

High-frequency transcranial magnetic stimulation decreases cigarette smoking

Wohlleben, G.

Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Wolf, J.

Aripiprazole, a novel antipsychotic. Report on a case series of 8 schizophrenic patients with emphasis on negative symptoms, libido and weight

Wolf, K.

Gender effects in pharmacological relapse prevention of alcoholism

Sex-specific differences in pain-induced facial muscle activation

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Wolf, R.

Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?

Wolfersdorf, M.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Leptin levels of alcohol abstainers and detoxification patients are not different

Wolźniak, A.

Polish version of Medication Adherence Rating Scale (MARS)

Smoking in schizophrenia –Relationship to psychopathology and side-effects

Wotjak, C. T.

The endocannabinoid system of the brain: A potential therapeutic target for the treatment of anxiety disorders in traumatised patients?

The roles of the endogenous cannabinoid system in learning and memory in mice

Wrase, J.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Wurm, G.

Naturalistic follow-up study of pharmacologic treated patients with anxiety disorders

Wurst, F. M.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Leptin levels of alcohol abstainers and detoxification patients are not different

Wurst, W.

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Wuttke, H.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates

Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Xu, K.

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Yacubian, J.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Yassouridis, A.

Influence of sleep deprivation on plasma ghrelin levels in healthy subjects

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

Yavuz, A.

Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study

Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

Yehuda, R.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Zaudig, M.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Zernig, G.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Zetzsche, T.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study

Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Ziegenhorn, A. A.

Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder

Zieglgänsberger, W.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Zietz, B.

Risk of diabetes and schizophrenia

Zihl, J.

Neuropsychological deficits and long-term outcomes in patients with affective disorders

Zill, P.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients

Gender influence on pharmacogenetic prediction of antidepressive efficacy

Zilles, K.

Alcohol-craving: Therapeutic effects using fMRI

Zimbelmann, M.

Validation of a genetic mouse model for anxiety and comorbid depression

Zimmer, A.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Zimmermann, S.

Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

Zobel, A.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Zowe, M.

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients

Zwanzger, P.

Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Gender influence on pharmacogenetic prediction of antidepressive efficacy

Zwisler, R.

Antidepressants from an internet-patients’ viewpoint